119 related articles for article (PubMed ID: 9466279)
1. Pulmonary toxicity of high-dose chemotherapy for breast cancer: a non-invasive approach to diagnosis and treatment.
Chap L; Shpiner R; Levine M; Norton L; Lill M; Glaspy J
Bone Marrow Transplant; 1997 Dec; 20(12):1063-7. PubMed ID: 9466279
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary toxicity syndrome in breast cancer patients undergoing BCNU-containing high-dose chemotherapy and autologous hematopoietic cell transplantation.
Cao TM; Negrin RS; Stockerl-Goldstein KE; Johnston LJ; Shizuru JA; Taylor TL; Rizk NW; Wong RM; Blume KG; Hu WW
Biol Blood Marrow Transplant; 2000; 6(4):387-94. PubMed ID: 10917574
[TBL] [Abstract][Full Text] [Related]
3. Acute lung injury following treatment with high-dose cyclophosphamide, cisplatin, and carmustine: pharmacodynamic evaluation of carmustine.
Jones RB; Matthes S; Shpall EJ; Fisher JH; Stemmer SM; Dufton C; Stephens JK; Bearman SI
J Natl Cancer Inst; 1993 Apr; 85(8):640-7. PubMed ID: 8468721
[TBL] [Abstract][Full Text] [Related]
4. High-dose chemotherapy with autologous peripheral blood progenitor cell support for primary breast cancer in patients with 4-9 involved axillary lymph nodes.
Bearman SI; Overmoyer BA; Bolwell BJ; Taylor CW; Shpall EJ; Cagnoni PJ; Mechling BE; Ronk B; Barón AE; Purdy MH; Ross M; Jones RB
Bone Marrow Transplant; 1997 Dec; 20(11):931-7. PubMed ID: 9422471
[TBL] [Abstract][Full Text] [Related]
5. Inhaled steroids as prophylaxis for delayed pulmonary toxicity syndrome in breast cancer patients undergoing high-dose chemotherapy and autologous stem cell transplantation.
McGaughey DS; Nikcevich DA; Long GD; Vredenburgh JJ; Rizzieri D; Smith CA; Broadwater G; Loftis JS; McDonald C; Morris AK; Folz RF; Chao NF
Biol Blood Marrow Transplant; 2001; 7(5):274-8. PubMed ID: 11400949
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary toxicity following carmustine-based preparative regimens and autologous peripheral blood progenitor cell transplantation in hematological malignancies.
Alessandrino EP; Bernasconi P; Colombo A; Caldera D; Martinelli G; Vitulo P; Malcovati L; Nascimbene C; Varettoni M; Volpini E; Klersy C; Bernasconi C
Bone Marrow Transplant; 2000 Feb; 25(3):309-13. PubMed ID: 10673703
[TBL] [Abstract][Full Text] [Related]
7. Predictors for pneumonitis during locoregional radiotherapy in high-risk patients with breast carcinoma treated with high-dose chemotherapy and stem-cell rescue.
Lind PA; Marks LB; Jamieson TA; Carter DL; Vredenburgh JJ; Folz RJ; Prosnitz LR
Cancer; 2002 Jun; 94(11):2821-9. PubMed ID: 12115368
[TBL] [Abstract][Full Text] [Related]
8. Cardiac sequelae of doxorubicin and paclitaxel as induction chemotherapy prior to high-dose chemotherapy and peripheral blood progenitor cell transplantation in women with high-risk primary or metastatic breast cancer.
Klein JL; Rey PM; Dansey RD; Karanes C; Du W; Abella E; Cassells L; Hamm C; Peters WP; Baynes RD
Bone Marrow Transplant; 2000 May; 25(10):1047-52. PubMed ID: 10828864
[TBL] [Abstract][Full Text] [Related]
9. Empiric prednisone therapy for pulmonary toxic reaction after high-dose chemotherapy containing carmustine (BCNU).
Kalaycioglu M; Kavuru M; Tuason L; Bolwell B
Chest; 1995 Feb; 107(2):482-7. PubMed ID: 7842781
[TBL] [Abstract][Full Text] [Related]
10. Association of high-dose cyclophosphamide, cisplatin, and carmustine pharmacokinetics with survival, toxicity, and dosing weight in patients with primary breast cancer.
Petros WP; Broadwater G; Berry D; Jones RB; Vredenburgh JJ; Gilbert CJ; Gibbs JP; Colvin OM; Peters WP
Clin Cancer Res; 2002 Mar; 8(3):698-705. PubMed ID: 11895898
[TBL] [Abstract][Full Text] [Related]
11. High-dose chemotherapy and autologous peripheral blood progenitor cell transplant for the treatment of Hodgkin's disease.
Weaver CH; Schwartzberg L; Li W; Hazelton B; West W
Bone Marrow Transplant; 1996 May; 17(5):715-21. PubMed ID: 8733687
[TBL] [Abstract][Full Text] [Related]
12. A randomized trial of amifostine and carmustine-containing chemotherapy to assess lung-protective effects.
Jones RB; Stockerl-Goldstein KE; Klein J; Murphy J; Blume KG; Dansey R; Martinez C; Matthes S; Nieto Y
Biol Blood Marrow Transplant; 2004 Apr; 10(4):276-82. PubMed ID: 15077226
[TBL] [Abstract][Full Text] [Related]
13. High-dose BCNU and autologous progenitor cell transplantation given with intra-arterial cisplatinum and simultaneous radiotherapy in the treatment of high-grade gliomas: benefit for selected patients.
Fernández-Hidalgo OA; Vanaclocha V; Vieitez JM; Aristu JJ; Rebollo J; Gúrpide A; Aramendía JM; Moreno-Palanques R; Martín-Algarra S; Subirá ML; Brugarolas A
Bone Marrow Transplant; 1996 Jul; 18(1):143-9. PubMed ID: 8832007
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary drug toxicity in patients with primary breast cancer treated with high-dose combination chemotherapy and autologous bone marrow transplantation.
Todd NW; Peters WP; Ost AH; Roggli VL; Piantadosi CA
Am Rev Respir Dis; 1993 May; 147(5):1264-70. PubMed ID: 8484641
[TBL] [Abstract][Full Text] [Related]
15. Delayed pulmonary toxicity syndrome following high-dose chemotherapy and bone marrow transplantation for breast cancer.
Wilczynski SW; Erasmus JJ; Petros WP; Vredenburgh JJ; Folz RJ
Am J Respir Crit Care Med; 1998 Feb; 157(2):565-73. PubMed ID: 9476874
[TBL] [Abstract][Full Text] [Related]
16. Regimen-related toxicity and non-relapse mortality with high-dose cyclophosphamide, carmustine (BCNU) and etoposide (VP16-213) (CBV) and CBV plus cisplatin (CBVP) followed by autologous stem cell transplantation in patients with Hodgkin's disease.
Reece DE; Nevill TJ; Sayegh A; Spinelli JJ; Brockington DA; Barnett MJ; Klingemann HG; Connors JM; Nantel SH; Shepherd JD; Sutherland HJ; Voss NJ; Fairey RN; O'Reilly SE; Phillips GL
Bone Marrow Transplant; 1999 Jun; 23(11):1131-8. PubMed ID: 10382952
[TBL] [Abstract][Full Text] [Related]
17. Thrombotic microangiopathy as a complication of high-dose chemotherapy for breast cancer.
Fisher DC; Sherrill GB; Hussein A; Rubin P; Vredenburgh JJ; Elkordy M; Ross M; Petros W; Peters WP
Bone Marrow Transplant; 1996 Jul; 18(1):193-8. PubMed ID: 8832014
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary toxicity syndrome following CDEP (cyclophosphamide, dexamethasone, etoposide, cisplatin) chemotherapy.
Fassas A; Gojo I; Rapoport A; Cottler-Fox M; Meisenberg B; Papadimitriou JC; Tricot G
Bone Marrow Transplant; 2001 Aug; 28(4):399-403. PubMed ID: 11571514
[TBL] [Abstract][Full Text] [Related]
19. Idiopathic pneumonia syndrome after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for high-risk breast cancer.
Wong R; Rondon G; Saliba RM; Shannon VR; Giralt SA; Champlin RE; Ueno NT
Bone Marrow Transplant; 2003 Jun; 31(12):1157-63. PubMed ID: 12796796
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary toxicity of induction chemotherapy prior to standard or high-dose chemotherapy with autologous hematopoietic support.
Bhalla KS; Wilczynski SW; Abushamaa AM; Petros WP; McDonald CS; Loftis JS; Chao NJ; Vredenburgh JJ; Folz RJ
Am J Respir Crit Care Med; 2000 Jan; 161(1):17-25. PubMed ID: 10619792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
